MFTZ-1, an actinomycetes subspecies-derived antitumor macrolide, functions as a novel topoisomerase II poison | |
Xie, Cheng-Ying; Zhu, Hong; Lin, Li-Fling; Miao, Ze-Hong; Geng, Mei-Yu; Cai, Yu-Jun; Chen, Yi; Zhao, Hua-Jun; Luo, Hai-Bin; Zhang, Xiong-Wen; Fan, Li-Ming; Shen, Yue-Mao; Ding, Jian | |
2007-11-01 | |
发表期刊 | MOLECULAR CANCER THERAPEUTICS
![]() |
卷号 | 6期号:11页码:3059-3070 |
摘要 | 14-Ethyl-2,5,11-trimethyl-4,13,19,20-tetraoxa-tricyclo [14.2.1.1(7,10)]eicosane-3,12-dione (MFTZ-1), a new macrolide compound isolated from Streptomyces sp. ls9131, displayed wide cytotoxicity in human tumor cell lines with an average IC50 of 0.905 mu mol/L. Notably, MFTZ-1 showed significant cytotoxicity in the three multidrug resistance cell lines with an average resistance factor of 2.08. The in vivo experiments showed that MFTZ-1 had inhibitory effects on the human ovarian carcinoma HO-8910 cell line xenotransplanted in nude mice. Further studies showed that MFTZ-1 induced DNA double-strand breaks and triggered mitochondria-dependent apoptosis in human leukemia HL-60 cells. Using a yeast genetic system, we found that topoisomerase (Topo) II rather than Topo I was the primary cellular target of MFTZ-1. Most importantly, MFTZ-1 functions as a novel nonintercalative Topo II poison via binding to ATPase of Topo II, characterized by its strong inhibition on the decatenation and relaxation of Topo II. The capacity of MFTZ-1 to stabilize Topo II-DNA covalent complexes was comparable with that of the classic Topo II poison, etoposide. Moreover, using a Topo II catalytic inhibitor aclarubicin and Topo [I-deficient HL-60/MX2 cells, we further showed that MFTZ-1-triggered DNA doublestrand breaks and apoptosis occurred in a Topo II-dependent manner. Together, the well-defined Topo II-poisoning function and the potent antitumor activity, with the appreciable anti-multidrug resistance action in particular, promises MFTZ-1 as a novel potential Topo II-targeted agent, which merits further research and development. [Mol Cancer Ther 2007;6(11):3059 - 70]. |
DOI | 10.1158/1535-7163.MCT-07-0014 |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000251096600024 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/23849 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China 3.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China |
推荐引用方式 GB/T 7714 | Xie, Cheng-Ying,Zhu, Hong,Lin, Li-Fling,et al. MFTZ-1, an actinomycetes subspecies-derived antitumor macrolide, functions as a novel topoisomerase II poison[J]. MOLECULAR CANCER THERAPEUTICS,2007,6(11):3059-3070. |
APA | Xie, Cheng-Ying.,Zhu, Hong.,Lin, Li-Fling.,Miao, Ze-Hong.,Geng, Mei-Yu.,...&Ding, Jian.(2007).MFTZ-1, an actinomycetes subspecies-derived antitumor macrolide, functions as a novel topoisomerase II poison.MOLECULAR CANCER THERAPEUTICS,6(11),3059-3070. |
MLA | Xie, Cheng-Ying,et al."MFTZ-1, an actinomycetes subspecies-derived antitumor macrolide, functions as a novel topoisomerase II poison".MOLECULAR CANCER THERAPEUTICS 6.11(2007):3059-3070. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
xie2007.pdf(547KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论